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Dyspepsia is a common presenting symptom com­
plex in primary care all over the world, accounting 
for 3 ­ 4% of primary healthcare visits.[1] Population­
based surveys in many countries have revealed a 
highly variable prevalence, from 1.8% to 57%, with 
a global average of 20.8% in the published literature.[2] These 
geographical differences are not fully accounted for by variations in 
symptom definition, although, as expected, large differences have 
been noted between less strict and more strict definitions of the dys­
peptic symptom complex.[2]
Data on the frequency of dyspepsia in primary care settings in 
Africa are lacking, with only two prior studies having been published, 
both from Nigeria.[3,4] However, while dyspepsia is a frequent reason 
for clinic and hospital attendance across Africa, it is not clear what 
proportion of symptomatic patients seek medical treatment. No 
previous studies have looked at the impact on quality of life of 
dyspeptic symptoms in Africans living in the community, although 
studies in other populations have shown a significant impact on 
quality of life, but not mortality.[5,6]
The vast majority of African studies of dyspepsia have been done in 
endoscopy or tertiary clinic referral populations. These populations 
are not representative of the community, for whom the burden of 
disease is unknown. This study seeks to reduce this knowledge gap 
by characterising the burden of dyspepsia in a presumed well, clearly 
defined sample of healthcare workers (HCWs) in Rwanda, to provide 
an accurate measure of the frequency and distribution of dyspeptic 
symptoms among a community­representative sample, and the 
quality­of­life costs associated with their symptoms.
Methods
This cross­sectional survey was conducted in Butare University 
Teaching Hospital (BUTH), located in the Huye District in the 
Southern Province of Rwanda, during October and November 2013, 
in conjunction with a larger study evaluating viral hepatitis burden 
and risk determinants among HCWs. The hospital is the sole tertiary 
referral centre for Southern Rwanda, with 500 beds and a catchment 
population of about 5 million people. The hospital also serves as a 
teaching site for Rwanda’s sole medical school. The hospital employed 
747 personnel at the time of the study: 419 clinical HCWs, 78 
administrative HCWs and 250 cleaners.
Study site and sample size
The survey was powered to assess the prevalence of dyspepsia in the 
population. The survey’s sample size was estimated at 373 subjects, 
based on a closed eligible population of 747 HCWs at BUTH, with a 
presumed dyspepsia prevalence of 35% based on prior community­
based African studies,[3,4] and aiming for a 5% relative standard error 
in the measurement of dyspepsia prevalence at an alpha level of 
0.05. All HCWs were invited to attend the study centre for free viral 
hepatitis testing, and then were offered participation in this study 
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Background. Dyspepsia has been demonstrated worldwide to have major personal and societal impacts, but data on the burden of this 
disease in Africa are lacking.
Objective. To document the prevalence of dyspepsia and its quality­of­life impact among healthcare workers (HCWs) at Butare University 
Teaching Hospital (BUTH), Rwanda.
Methods. A cross­sectional survey among consenting HCWs at BUTH was conducted. Multilingual interviewers guided participants 
through validated questionnaires, including the Short­Form Leeds Dyspepsia Questionnaire (SF­LDQ), to detect the presence and 
frequency of dyspeptic symptoms, and the Short­Form Nepean Dyspepsia Index (SF­NDI), to examine the impact of dyspepsia on quality 
of life.
Results. The study included 378 enrolled HCWs, all of whom provided responses to the SF­LDQ and 356 of whom responded to the 
SF­NDI. The prevalence of dyspepsia in the study population was 38.9% (147/378). Of these 147 HCWs, 79 (53.7%) had very mild 
dyspepsia, 33 (22.4%) had mild dyspepsia, 20 (13.6%) had moderate dyspepsia and 15 (10.2%) had severe dyspepsia. Females were 
more likely to complain of dyspepsia than males (98/206 v. 49/172; odds ratio (OR) 2.3; 95% confidence interval (CI) 1.5 ­ 3.5; p<0.001). 
Participants with dyspepsia of at least mild severity had SF­NDI scores reflecting reduced quality of life when compared with non­dyspeptic 
participants (OR 17.0; 95% CI 5.0 ­ 57.1; p<0.001), with most marked effects on the ‘tension’ and ‘eating and drinking’ subdomains of the 
SF­NDI.
Conclusion. The prevalence of dyspepsia among HCWs in Rwanda is high and is associated with lowered quality of life.
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on their arrival, independent of the testing. Sampling of all eligible 
HCWs was consecutive, without random selection.
Inclusion and exclusion criteria
All consenting HCWs aged ≥18 years and currently employed at 
BUTH were eligible for study enrolment. HCWs on leave or not 
currently working because of illness at the time of the study were 
not invited. Postgraduate students on clinical placements were 
considered as HCWs, but undergraduate students were not eligible.
Questionnaires 
Questionnaires were administered and filled out by trained 
interviewers with language skills in English, French and Kinyarwanda.
The questionnaire was made up of three sections: (i) socio­
demographic data; (ii) the Short­Form Leeds Dyspepsia Questionnaire 
(SF­LDQ); and (iii) the Short­Form Nepean Dyspepsia Index 
(SF­NDI).
The SF­LDQ was used to detect the presence and frequency of 
dyspeptic symptoms, and the SF­NDI to examine the impact of 
dyspepsia on quality of life.
Where possible, the survey was administered in English, but if 
necessary the interviewer translated the questions into French or 
Kinyarwanda. Prior to survey administration, an agreed wording 
for the oral translation of the English instruments into French 
and Kinyarwanda was completed, involving translation and back­
translation of the survey instrument by a group of multilingual 
medical experts. The LDQ and SF­NDI instruments were tested for 
reliability in a pilot study comprising ten HCWs eligible for study 
entry but not forming part of the final data set. Qualitative data were 
obtained from this focus group to improve the questionnaire.
The Short-Form Leeds Dyspepsia Questionnaire
The SF­LDQ consists of eight items that assess for the presence 
and severity of dyspepsia by measuring the frequency and severity 
of upper abdominal pain/discomfort, heartburn, regurgitation and 
nausea. It was developed from the Leeds Dyspepsia Questionnaire 
(LDQ), a longer form survey.[7] Possible scores range from 0 to 
32 with higher values corresponding with increasing severity of 
dyspepsia. The developers of the SF­LDQ have defined a score of  0 
as ‘no dyspepsia’, a score of 1 ­ 4 as ‘very mild dyspepsia’, a score of 
5 ­ 8 as ‘mild dyspepsia’, a score of 9 ­ 15 as ‘moderate dyspepsia’ 
and a score >15 as indicative of ‘severe dyspepsia’.[8] In the design 
of the study, we planned to analyse these results categorically but 
also dichotomously, with those in the ‘no dyspepsia’ and ‘very mild 
dyspepsia’ groups defined as non­dyspeptic (i.e. those with an 
SF­LDQ score of <5). The LDQ and SF­LDQ have been used in many 
studies and have previously been validated as accurate and reliable 
tools to assess the presence and severity of dyspepsia in multiple, 
diverse and multicultural populations.[9,10]
The Short-Form Nepean Dyspepsia Index
The SF­NDI is a questionnaire comprising ten items, making up five 
subscales of two items each that examine the impact of dyspepsia on 
various domains of the quality of life of patients, including tension/
anxiety, disruption of regular eating/drinking, knowledge and control 
over disease symptoms and interference with work/study.[11] It is also 
based on an earlier tool, the Nepean Dyspepsia Index (NDI), which 
was developed to study quality of life in functional dyspepsia.[12]
Each item is measured by a 5­point Likert scale ranging from 1 
(‘not at all’ or ‘not applicable’) to 5 (‘extremely’). Individual items in 
each subscale are added to obtain a score range from 10 (lowest score) 
to 100 (highest score). A higher score on the SF­NDI is indicative of 
a poorer quality of life, with patients with scores >15 having been 
shown by the designers of this instrument to have significantly 
reduced health­related quality of life. The NDI and SF­NDI have been 
used in many studies and have been validated in various populations 
as accurate and reliable tools to measure the impact of dyspepsia on 
quality of life.[13,14]
Data analysis
Key outcomes for this study include the frequency and quality­of­
life impact of dyspepsia, measured by the SF­LDQ and SF­NDI, 
respectively. Demographic data (age, gender, marital status, 
department of work, profession and educational level), smoking, and 
alcohol, aspirin and non­steroidal drug intake are probable predictors 
of dyspepsia, while we expect these factors may also be co­variable 
with the quality­of­life impact of dyspepsia, and these were assessed 
in the sociodemographic section of the questionnaire.
All data were collected using a questionnaire uploaded on personal 
digital assistants. Query programs were written into the database to 
limit entry of incorrect data and to ensure data quality. The study 
co­ordinator and data manager reviewed the data and all associated 
queries daily for completeness and accuracy. Any missing data were 
coded as such and excluded from analysis of that variable.
The data were then transferred into SPSS (version 16.0; IBM, USA) 
and Stata (version 12.1; Stata Corp, USA) for data analysis. Outcome 
variables were the scores on SF­LDQ and SF­NDI. Comparisons 
of characteristics between groups of study participants were made 
using the χ2 test for categorical variables and one­way analysis 
of variance (ANOVA) for non­normally distributed continuous 
variables. Associations between predictor variables and outcomes of 
interest were estimated using both univariate and multivariate logistic 
regression, for those variables found to be significant by univariate 
analysis. In the final interpretation of results, a p­value of <0.05 was 
considered statistically significant.
Ethical considerations
Written informed consent was required from all study participants. 
The study was approved by the Butare University Teaching Hospital 
Research and Ethics Commission and the University of Rwanda 
School of Medicine Research Commission.
Results
The questionnaire was administered to 378 HCWs at BUTH, all of 
whom provided responses to SF­LDQ and 356 of whom responded 
to the SF­NDI.
The study population was generally young (mean 34.1 years, 
range 18 ­ 63), with a slight female preponderance (54.5%). 
The majority were tertiary educated (58.7%), but a significant 
proportion (18%) had not attended secondary school. Ancillary 
staff, including cleaners and administration staff, outnumbered 
both nurses and doctors in the study population. All major hospital 
departments were represented, in approximate proportion to their 
number of staff (Table 1). The staff included in the study did not 
differ significantly in age, gender or department of work from those 
who were not included.
Using a broad definition of (any) dyspepsia, the prevalence of 
dyspepsia in the study population was 38.9% (147/378). Of these 
147 HCWs, 79 (53.7%) had very mild dyspepsia, 33 (22.4%) mild 
dyspepsia, 20 (13.6%) moderate dyspepsia and 15 (10.2%) severe 
dyspepsia. Females were more likely to complain of dyspepsia 
than males (98/206 v. 49/172, odds ratio (OR) 2.3; 95% confidence 
interval (CI) 1.5 ­ 3.5; p<0.001). Higher education levels were asso­
ciated with a lower risk of dyspeptic symptoms (OR 0.6; p=0.015), 
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but conventional risk factors for dyspepsia, 
including smoking and use of alcohol, non­
steroidal anti­inflammatory medications 
and aspirin, were not associated with 
dyspeptic symptoms in this population 
(Table 2). Indigestion was the most 
frequent symptom type reported (in 25% 
of study subjects), with heartburn (22%), 
regurgitation (15%) and nausea (9%) all 
both less frequently observed and showing 
lower frequency of lifestyle interference on 
the SF­LDQ (Table 3).
On multivariate analysis, gender 
(p<0.001) and level of education (p=0.006) 
remained highly predictive of dyspepsia, 
but no other factors in the model were 
statistically significant, with the exception 
of the consumption of alcohol, which was 
associated with a borderline lower risk of 
dyspepsia (p=0.043).
Participants with dyspepsia had reduced 
quality­of­life scores, as measured by 
the SF­NDI, when compared with non­
dyspeptic participants (p<0.001), the 
most marked effects being on the tension 
and eating and drinking subdomains of 
the SF­NDI. An appreciable difference in 
quality of life was apparent, with the most 
marked reduction seen in subjects with at 
least mild severity dyspepsia, compared 
with those suffering no or very mild 
dyspepsia (sum of squares by ANOVA 
779.27; p<0.001) (Table 4).
As an alternative measure, the proportion 
of subjects with reduced quality of life (def­
ined as an SF­NDI of ≥15 points, consisting 
of the bottom 8% of the population) in 
each dyspeptic symptom group was also 
calculated, with 1.4% and 10.7% of non­ and 
very mildly dyspeptic patients meeting this 
threshold, compared with 25.8%, 31.6% and 
33.3% of mildly, moderately and severely 
dyspeptic patients.
Analysis of the predominant symptom and 
covariance in symptoms on the SF­LDQ was 
also undertaken, with the goal of defining 
patients into separate dyspeptic symptom 
complex groups. These were defined as 
predominant epigastric pain (‘ulcer­like’), 
predominant heartburn or regurgitation 
(‘reflux­like’), predominant nausea (‘dys­
motility­like’) and mixed groups. Of 90 
patients with dyspepsia and a predominant 
symptom available for analysis, 38 (42.2%) 
described ulcer­like symptoms, 37 (41.1%) 
Table 1. Baseline characteristics and 
distribution of 378 study participants
Variable n (%) 
Gender  
Male 172 (45.5)
Female 206 (54.5)
Age group (years)  
18 ­ 29 125 (33.1)
30 ­ 49 232 (61.3)
≥50 21 (5.6)
Marital status  
Single 131 (34.6)
Married 232 (61.4)
Divorced/separated 4 (1.1)
Widowed 9 (2.4)
Living together 2 (0.5)
Current department of work  
Medicine 47 (12.4)
Obstetrics & gynaecology 30 (7.9)
Paediatrics 47 (12.4)
Surgery 52 (13.9)
Administration 28 (7.4)
Laboratory 11(2.9)
Sterilisation 6 (1.7)
 Other departments (cleaning 
services, etc.) 156 (41.4)
Education  
None 3 (0.8)
Primary level 65 (17.2)
Secondary/vocational 88 (23.3)
University/other tertiary 222 (58.7)
Staffing group  
Nurses 123 (32.5)
Doctors 40 (10.6)
 Others (cleaners, laboratory 
staff, etc.) 215 (56.9)
Table 2. Dyspepsia prevalence and its association with demographic and lifestyle 
factors, by univariate analysis 
Dyspepsia, n/total (%) OR (CI) p-value
Overall 147/378 (38.9)
Gender
Male 49/172 (28.5) (ref.)
Female 98/206 (47.6) 2.28 (1.48 ­ 3.50) <0.001
Marital status
Single 45/131 (34.4)
Married 96/232 (41.4)
Widowed 4/9 (44.4)
Other 2/6 (33.3) NS
Age (years)
<30 64/150 (42.7)
30 ­ 49 69/193 (35.8)
≥50 14/35 (40.0) NS
Education level
Primary or secondary* 72/156 (46.2) (ref.)
Tertiary 75/222 (33.8) 0.60 (0.39­0.91) 0.015
Smoking
Never 133/339 (39.2)
Past 10/32 (31.3)
Current 4/7 (57.1) NS
Alcohol
Nil 101/241 (41.9)
Any current 46/137 (33.6) NS
NSAID use
Never 29/81 (35.8)
Past 96/256 (37.5)
Current 22/43 (51.2) NS
(ref.) = referent population for odds ratio calculations.
*NB. The primary and secondary education group includes HCWs with vocational training.
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reflux­like symptoms, 8 (8.9%) dysmotility­like symptoms, and 7 
(7.8%) mixed symptoms.
There was a significantly higher SF­LDQ (t=–3.314, p=0.009) 
among patients with reflux­like or mixed symptoms (mean 8.25) 
than among those with ulcer­like or dysmotility­like symptoms 
(mean  4.94). However, quality of life measured by the SF­NDI was 
not significantly different between these groups (means 13.16 v. 
12.48; p>0.05).
Discussion
Dyspepsia affected more than a third of Rwandan HCWs in this 
study, and had a significant impact on wellbeing, with symptoms 
severe enough to impair the quality of life of almost a third of affected 
HCWs. Ulcer­like and reflux­like symptoms were equally common, 
perhaps surprisingly, given how infrequently gastro­oesophageal 
reflux is diagnosed in African endoscopic series. The observed 
dyspepsia prevalence is at the high end of the range garnered from 
studies in other parts of the world, although these frequencies depend 
greatly on the definition of dyspepsia used in the study.[2]
One of the key challenges in studying dyspepsia is a lack of a 
clear, agreed standard definition of dyspeptic symptoms. Older 
studies tended to use broad descriptive questions on the presence of 
epigastric discomfort. More recently, the Rome II­III criteria have 
been developed, which attempt to draw a distinction between reflux 
symptoms and dyspepsia in order to distinguish gastro­oesophageal 
reflux disease from functional dyspepsia, but have met with a mixed 
reception. As a result, a variety of definitions remain in use, with 
simplicity, prior multicultural validity and ease of administration 
being our key criteria in choosing the SF­LDQ and SF­NDI for this 
study.
The SF­LDQ is based upon a broad definition of dyspepsia, not 
attempting to exclude reflux symptoms from the definition, and 
assessing symptoms over a 2­month period. In a recent meta­analysis 
by Ford et al.,[2] using a broad definition of this type gave a 29.5% 
pooled prevalence of dyspepsia. However, very few of the studies 
previously reported have used face­to­face interviews; those that 
did reported higher than average prevalences, pointing to a possible 
systematic effect of this data acquisition method on reported dyspepsia 
prevalence. While the SF­LDQ only assesses a limited range of 
dyspeptic symptoms, and does not include assessment of postprandial 
symptoms, which have been highly prevalent in Western studies, 
correlation between the SF­LDQ and other lengthier tools that include 
such symptoms has been high in published validation studies.[8,9]
As a symptom complex, uninvestigated dyspepsia does not have 
a single underlying pathological mechanism. Putative contributing 
factors include Helicobacter pylori infection, gastric acid and gastric 
dysmotility.[15] In Western populations, about 80% of patients with 
uninvestigated dyspepsia have a final diagnosis of functional dyspepsia 
following investigation.[6] The pathogenesis of functional dyspepsia is 
debated, and has not been well studied in areas with a high prevalence 
of H. pylori infection, although a recent observational study suggested 
a role for H. pylori and associated microscopic duodenitis.[16]
Traditional risk factors such as alcohol, smoking and non­
steroidal anti­inflammatory drug (NSAID) use were not found 
Table 4. Severity of dyspepsia and impact on quality of life, as measured by mean SF-NDI scores in 356 subjects*
No dyspepsia Very mild dyspepsia Mild dyspepsia Moderate dyspepsia Severe dyspepsia p-value
SF­NDI total score 10.31 11.21 13.90 14.47 15.20 <0.001 
SF­NDI: Tension 2.10 2.57 3.39 3.68 3.93 <0.001
SF­NDI: Interference with 
ADLs
2.06 2.24 2.68 2.84 2.87 <0.001
SF­NDI: Eating/drinking 2.04 2.19 2.71 3.37 3.07 <0.001
SF­NDI: Knowledge/
control
2.06 2.11 2.55 2.16 2.67 0.004
SF­NDI: Work/study 2.05 2.11 2.58 2.42 2.67 <0.001
ADLs = activities of daily living.
*SF­NDI scores range from 10 to 50, with higher scores indicating more severely impaired quality of life. The last five rows refer to SF­NDI subdomains, each of which range from 2 to 10. p­values 
were calculated by Mann­Whitney U­tests, comparing patients with no or very mild dyspepsia with those with more severe dyspepsia.
Table 3. Frequency and lifestyle interference of each SF-LDQ 
symptom type in study subjects
Symptom type
Symptom 
frequency (%)
Interference with 
lifestyle frequency (%)
Indigestion
Never 281 (74) 322 (85)
< monthly 34 (9) 10(3)
> monthly, < weekly 31 (8) 20 (5)
> weekly, < daily 23 (6) 17 (5)
> daily 9 (2) 9(2)
Heartburn
Never 298 (79) 329 (87)
< monthly 26 (7) 11 (3)
> monthly, < weekly 26 (7) 14 (4)
> weekly, < daily 18 (5) 14 (4)
> daily 10 (3) 10 (3)
Regurgitation
Never 320 (85) 353 (93)
< monthly 23 (6) 7 (2)
> monthly, < weekly 18 (5) 8 (2)
> weekly, < daily 12 (3) 6 (2)
> daily 5 (1) 4 (1)
Nausea
Never 343 (91) 355 (94)
< monthly 20 (5) 9 (2)
> monthly, < weekly 4 (1) 4 (1)
> weekly, < daily 6 (2) 5 (1)
> daily 5 (1) 5 (1)
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to be associated with symptoms of dyspepsia in our study. While 
this initially appears surprising and is in contrast to the wider 
literature,[2] there are several good reasons why this might be 
the case among HCWs. First, HCWs are more likely to have an 
understanding of the link between such risk factors and the onset 
of dyspeptic symptoms. Secondly and more speculatively, HCWs 
might be more amenable to changing their behaviours in response 
to this knowledge, even without medical attention. As this study was 
cross­sectional, it was unable to examine the effects of dyspepsia on 
these health­related behaviours over time.
Among Rwandan HCWs in this study, women were more likely 
to complain of dyspeptic symptoms than men, and more likely 
to suffer lower quality of life as a result. This is in contrast with 
the only previous studies of dyspepsia in Africa, conducted in 
Nigeria,[3,4] where men had a similar rate to women (OR 0.93; 95% 
CI 0.73 ­ 1.19.[2] It should be noted that there are significant cultural 
variations between African nations, and it may be that the role of 
gender in illness behaviour is significantly different in Nigeria and 
Rwanda, as has been noted in other illnesses in disparate African 
contexts. The findings in our study are, however, quite consistent 
with the broader population­based international literature, where 
in a recent meta­analysis by Ford et al.[2] the pooled OR for women 
with dyspepsia requiring investigation was 1.24.
Higher levels of education were protective in this study of HCWs, 
although this may not be generalisable to non­healthcare education, 
as most participants in this study had higher qualifications in the 
health sciences. Previous studies in other populations have not shown 
any such association,[6] and it is possible that this represents a unique 
finding, as a result of the characteristics of this population. While H. 
pylori positivity rates were not measured in this study, it is interesting 
to note that higher education levels have been associated with lower 
rates of this infection among HCWs in other parts of the world, and 
this could explain this result.[17]
The presence and relative frequency of two major dyspeptic 
symptom complexes in this study is revealing. While the previous 
literature describes most African patients as suffering from ulcer­like 
symptoms, in our study reflux­like symptoms were just as common, 
and just as likely to be rated as the major symptom. While the 
SF­LDQ has two of four question groups related to reflux symptoms 
(heartburn and regurgitation) and this may explain the higher 
SF­LDQ scores among subjects with a predominantly reflux­based 
symptom complex, the quality­of­life impact measured by SF­NDI 
was similar for both groups, as with studies in other populations.[11,14]
In these previous studies, ulcer­like and reflux­like symptom 
complexes were associated with moderate responses to acid 
suppression with omeprazole, in contrast to those with dysmotility­
like symptoms.[18] H. pylori eradication has also been only modestly 
effective in treating dyspeptic symptoms in low­prevalence 
populations in the Western world. Whether these data can be 
extrapolated to Africa, where H. pylori carriage rates are much higher 
and the mind­body interplay around dyspepsia may differ, is unclear.
Study limitations and strengths
We studied HCWs, a relatively well­educated population with 
greater than average access to healthcare knowledge and resources. 
As such, especially given the protective effect of higher levels 
of education apparent in this population, the study is likely to 
underestimate rates of dyspepsia in the general Rwandan popu­
lation. Other potential reasons for a lower rate of dyspepsia in this 
population could include better quality of life, as lower quality of 
life has been shown to increase the incidence of new dyspepsia in 
a previous study.[19] The study population was based in a provincial 
town, and results may not be easily extrapolated to people leading a 
traditional village lifestyle.
However, the study being performed in HCWs also gives it some 
notable strengths. Firstly and most importantly, HCWs have a 
shared linguistic and pathophysiological understanding of clinical 
symptoms, which aids the validity of comparison with international 
cohorts by reducing the cultural gap. Secondly, most study subjects 
were able to understand both English and French, reducing the need 
to translate the tools. Thirdly, a relatively small, geographically close 
study population aided study logistics and maximised recruitment.
Our study nonetheless has several limitations. The cross­sectional 
methodology used made it impossible to determine the direction 
of effect in the association between dyspepsia and lower quality 
of life. It is possible that dyspepsia causes lower quality of life, but 
equally plausible that patients with lower quality of life might be 
more susceptible to the onset of dyspeptic symptoms; this complex 
interplay needs further study. Definitions of dyspepsia are culturally 
and linguistically bounded, and despite our efforts to translate and 
validate the SF­LDQ and SF­NDI, it is impossible to know whether 
these definitions fill exactly the same linguistic and cultural space 
when translated. Our study was of uninvestigated dyspepsia, and 
thus the study methodology was unable to distinguish organic and 
functional causes of dyspepsia, which might have a different natural 
history in African populations, although the quality­of­life impact 
of each has been similar in other populations.[6] This should be the 
subject of future research.
Conclusion
Dyspepsia is a significant symptom complex among HCWs in this 
Rwandan tertiary institution, and has a major quality­of­life impact 
in a proportion of these. Reflux­like symptoms were just as common 
as ulcer­like symptoms, in contrast to findings in endoscopy­based 
studies. HCWs have high levels of uncontrolled symptoms, and rates 
may be even higher in the general community because of less access 
to healthcare resources.
More resources need to be devoted to the diagnosis and management 
of upper abdominal symptoms in Rwanda and other similar resource­
poor areas. Finally, further research in population­based cohorts is 
needed to characterise prevalence, symptom­complex patterns and 
underlying diagnoses in the wider African population.
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